Sign In
Buy IPA
$1.62
+0 (+0%)
At Close: Jan 16, 2026
ImmunoPrecise Antibodies Ltd. (IPA) Q1 2023 Earnings Call Transcript
02:48pm, Wednesday, 14'th Sep 2022
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA ) Q1 2023 Earnings Conference Call September 14, 2022 10:30 AM ET Company Participants Jennifer Bath - President & CEO Brad McConn - CFO Ilse Roodink - Chief
IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2023 on September 14, 2022
09:03am, Thursday, 08'th Sep 2022
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #AI--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA), an advanced biotherapeutic research and techno
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2022 on July 29, 2022
08:04am, Tuesday, 26'th Jul 2022
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #AI--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA), an advanced biotherapeutic research and techno
ImmunoPrecise Antibodies Ltd. (IPA) CEO Jennifer Bath on Q3 2022 Results - Earnings Call Transcript
02:56pm, Wednesday, 16'th Mar 2022
ImmunoPrecise Antibodies Ltd. (IPA) CEO Jennifer Bath on Q3 2022 Results - Earnings Call Transcript
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibo
ImmunoPrecise's COVID-19 Antibody Cocktail Shows Neutralization Activity Against Omicron
08:43am, Monday, 31'st Jan 2022
Immunoprecise Antibodies Ltd IPA has released preclinical data for the PolyTope TATX-03 COVID-19 antibody cocktail. [ALERT] Nic Chahine shares his Bear Market Beating options trading strategy.
ImmunoPrecise Antibodies Ltd.'s (IPA) CEO Dr. Jennifer Bath on Q2 2022 Results - Earnings Call Transcript
10:34pm, Monday, 13'th Dec 2021
ImmunoPrecise Antibodies Ltd.'s (IPA) CEO Dr. Jennifer Bath on Q2 2022 Results - Earnings Call Transcript
ImmunoPrecise to Present at the Benchmark Company's Discovery One-on-One Virtual Video Investor Conference on Thursday December 2, 2021
08:02am, Wednesday, 24'th Nov 2021
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA) is presenting at the Benchmark Compa
ImmunoPrecise Announces At-The-Market Facility of up to US$50 Million
06:26pm, Wednesday, 13'th Oct 2021
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA), a leader in full-service therapeuti
Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration With Pierre Fabre
08:38am, Thursday, 07'th Oct 2021
VICTORIA, British Columbia & CASTRES, France--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA) and the Pierre Fab
ImmunoPrecise Antibodies Ltd. (IPA) CEO Jennifer Bath on Q1 2022 Results - Earnings Call Transcript
10:49pm, Thursday, 09'th Sep 2021
ImmunoPrecise Antibodies Ltd. (IPA) CEO Jennifer Bath on Q1 2022 Results - Earnings Call Transcript
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA), a leader in full-service, therapeutic antib
ImmunoPrecise Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2022
08:28am, Friday, 03'rd Sep 2021
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibo
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeuti
ImmunoPrecise Antibodies Ltd. (IPA) CEO Jennifer Bath on Q4 2021 Results - Earnings Call Transcript
05:30am, Sunday, 01'st Aug 2021
ImmunoPrecise Antibodies Ltd. (IPA) CEO Jennifer Bath on Q4 2021 Results - Earnings Call Transcript
